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Parkinson’s disease (PD) is the most common neurode-
generative movement disorder, characterized by progres-
sive degeneration of dopaminergic neurons in the
substantia nigra and the presence of Lewy bodies in the
affected neurons, comprised of aggregated a-synuclein
[1, 2]. PD can therefore be considered an example of a
protein-folding disorder [3]. Heat Shock Proteins (HSPs)
are the major chaperones mediating (re) folding of proteins,
ensuring that these proteins stay in their native formations
during conditions of stress to the cell [4]. We tested 27
genes encoding all members of the HSP10, HSP60, HSP70,
HSP90 and the heat shock factors (HSF) families and
assessed their association with PD.
Our discovery cohort was the Rotterdam Study (RS),
which is a population-based cohort study that investigates
the occurrence and determinants of diseases in the elderly
[5]. The Medical Ethics Committee at Erasmus Medical
Center approved the study protocol. Genomic DNA was
extracted from whole blood samples using standard meth-
ods [6]. Genome-wide SNP genotyping was performed
using Infinium II assay on the HumanHap550 Genotyping
BeadChips (Illumina Inc, San Diego, USA). Approxi-
mately 2 million SNPs were imputed using release 22
HapMap CEU population as reference. The imputations
were performed using MACH software (http://www.sph.
umich.edu/csg/abecasis/MACH/).
A total 3,828 SNPs in 27 genes were initially selected
for the association test on the basis of the following cri-
teria: (1) position within the genes of interest with a margin
of 100 kb on each side of the genes according to NCBI
build 36.3, (2) p-value for Hardy–Weinberg equilibrium
test C 0.0001, and (3) call rate C 95%. For further analysis
and selection of SNPs for replication analysis only SNPs
with an imputation quality greater than 80% and a minor
allele frequency (MAF) higher than 0.05 were selected.
We analyzed the individual SNPs using ProbABEL [7].
We used allele-based logistic regression to test the asso-
ciation between a single SNP and PD. Odds Ratios (ORs)
for each SNP were derived adjusting for age and sex. To
calculate empirical significance for SNPs, permutations
were performed per region of interest (ROI). Briefly, we
performed 10,000 replications with randomly allocated
phenotypes. To estimate empirical significance each
observed test statistic was compared with null statistics
obtained empirically and the P-value was estimated as the
proportion of replicas generating the test statistics greater
than or equal to the observed statistic.
For each suggestively associated ROI (Ppermuted \ 0.10)
we next selected the ‘independently associated’ SNPs in a
backward stepwise logistic regression until only nominally
significant SNPs remained in the model. These indepen-
dently associated SNPs were then followed up. Further
suggestively associated SNPs inside the gene were also sent
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for replication. For replication we used online available
genome wide association studies (GWAS) on PD and
selected the study from Simon-Sanchez et al. [8] published in
Nature Genetics in 2009. This study included a total of 5,197
PD cases and 8,803 controls. In their supplementary tables,
the authors present P-values and effect estimates for all SNPs
with a P-value lower than 1910-4 in the discovery stage.
General characteristics of the discovery population are
shown in Table 1. A total of 134 cases of Parkinson Dis-
ease were identified. The cases are significantly older than
controls. A summary of all SNPs tested in the HSP genes in
the discovery phase can be found in Supplementary
Table 1. As HSP10 (HSPE1) and HSP60 (HSPD1) are
located head to head on chromosome 2 these were taken as
1 Region of Interest (ROI) with 52 SNPs (Chaperonin).
The same applies to 3 HSP70 genes located on chromo-
some 6 with 148 SNPs (HSPA1).
Figure 1 shows an overview of the P-values in all genes
tested in RS1. After adjusting for multiple testing by per-
mutation analysis, 3 genes still showed evidence for asso-
cation to PD in RS1. These genes encode Chaperonin,
HSP70 member HSPA13 and HSF member HSF5. For
replication the following SNPs were selected: rs17730989
and rs788016 for Chaperonin, rs2822686 for HSPA13 and
rs9889631 for HSF5. Two SNPs in Chaperonin were
selected as both were intronic SNPs for HSPD1. The
results for the SNPs we attempted to replicate are in
Table 2. None of these SNPs had a P-value lower than
1910-4 in our replication sample. We did not find sig-
nificant evidence for an association between SNPs in or
directly flanking the HSP genes with PD.
Chaperonin was the best candidate for association with
PD to reach significance in the discovery cohort, but none
of the SNPs in HSPD1 were replicated. Chaperonin is an
interesting candidate for association with PD as it is the
major folding machine of the mitochondria [9]. Its
important influence on mitochondrial function is under-
lined by findings that yeast cells carying a null mutation in
HSP60 have severe defects in folding of mitochondrial
proteins and are non-viable [10]. In contrast, yeast cells
with conditional mutations in HSP60 tend to accumulate
misfolded proteins that are unable to perform their func-
tions, similar to a-synculein aggregation in PD [10].
The importance of mitochondrial dysfunction in PD is
widely accepted. All major genes previously identified for
familial PD influence mitochondrial functioning [11]. The
importance of HSPD1 in mitochondrial functioning could
be an explanation for the absence of an association with
PD. Only variants with very small ORs are to be expected
in such a critical gene, leaving our study underpowered to
reach statistical significance.
In summary, we examined associations between 3,828
SNPs in and around 27 genes encoding the Chaperonin,
HSP70, HSP90 and HSF gene families in two unrelated
cohorts, and found no statistically significant associations
with PD. Despite evidence on the protein level for
involvement of these genes, no large-scale studies have
Table 1 General characteristics for cases and controls in the dis-
covery cohort
Cases Controls
N 134 5,422
Age (mean ± SD) 74.2 ± 8.0 68.5 ± 8.5
Gender (% female) 58.5 53.0
Fig. 1 Summary results of all
SNPs tested. The
-log(P-values) of all SNPs
tested are presented, where the
SNPs are sorted on the genes on
x-axis. The horizontal lines
show the -log(P-values) of
0.05, 0.01 and 0.001
respectively
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been performed on the role of HSPs in patients with PD,
until now.
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Table 2 Association of the SNPs significantly associated with PD in the Rotterdam Study
Gene SNP Chr. Position RA Rotterdam Study Simon-Sanchez et al. [8]
Freq. OR 95% CI Freq. OR 95% CI
HSPD1 rs17730989 2 198,070,769 C 0.49 0.67 0.52–0.86 NF NF NF
HSPD1 rs788016 2 198,060,538 G 0.49 0.68 0.53–0.87 NF NF NF
HSPA13 rs2822686 21 14,773,971 T 0.82 0.61 0.46–0.8 NF NF NF
HSF5 rs9889631 17 53,985,358 T 0.93 0.55 0.37–0.81 NF NF NF
RS1 Rotterdam study, Chr chromosome, RA risk allele, Freq frequency, OR odds ratio, 95% CI 95% confidence interval, NF not found with a
P-value of 10-4
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